The AGL Energy (ASX: AGL) share price is down significantly since the company committed to its value destructive de-merger strategy. The possibility this de-merger could be defeated, creates an opportunity.
Cogstate (ASX: CGS), Pureprofile (ASX: PPL) and Genetic Signatures (ASX: GSS) each recently updated the market on Q3 FY 2022 results.
The last few days have really highlighted the risks facing DGL Group investors, so I’m going to sell all my remain DGL Group shares.
DGL Group (ASX: DGL) has upgraded its profit but the share price is up and shares are coming out of escrow.
EML Payments (ASX: EML) Chairman Peter Martin sold over $500k worth of shares just a few weeks before the EML Payments share price crashed.
Volpara (ASX: VHT) has experienced impressive growth in annualised recurring revenue over the last five years; but it’s still uncomfortably far from profitability.
Plus, closer a look at how many shares each Energy One director owns, and the tenure of CEO Shaun Ankers.
These four companies are businesses I want to own for the long term (and I’d like to own more of, at the right price).
A detailed look at the Pro Medicus major customer list, and why it needs both integrated delivery networks, and academic teaching hospitals.
The thesis is certainly off track but it’s much better to think things through slowly, than panic.
Warren Buffett liked to invest in businesses with these two key features, during the high inflation of the 1970s and 1980s.
This company has a few different features that mean it should fare much better than most in an inflationary environment.
These 5 well established businesses have all seen insiders snapping up shares at close to or above current prices.
The Russian invasion of Ukraine, covid, and low rates have lead to significant commodity price increases across the board.